The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Open accessAbstract
Objective: Polypharmacy is the concomitant use of several drugs by a single person, and it increases the risk of adverse drug-related events in older adults. Little is known about the epidemiology of polypharmacy at the population level. We aimed to measure the prevalence and incidence of polypharmacy and to investigate the associated factors. Methods: A prospective cohort study was conducted using register data with national coverage in Sweden. A total of 1,742,336 individuals aged ≥65 years at baseline (November 1, 2010) were included and followed until death or the end of the study (December 20, 2013). Results: On average, individuals were exposed to 4.6 (SD =4.0) drugs at baseline. The prevalence of polypharmacy (5+ drugs) was 44.0%, and the prevalence of excessive polypharmacy (10+ drugs) was 11.7%. The incidence rate of polypharmacy among individuals without polypharmacy at baseline was 19.9 per 100 person-years, ranging from 16.8% in individuals aged 65–74 years to 33.2% in those aged ≥95 years (adjusted hazard ratio [HR] =1.49, 95% confidence interval [CI] 1.42–1.56). The incidence rate of excessive polypharmacy was 8.0 per 100 person-years. Older adults using multi-dose dispensing were at significantly higher risk of developing incident polypharmacy compared with those receiving ordinary prescriptions (HR =1.51, 95% CI 1.47–1.55). When adjusting for confounders, living in nursing home was found to be associated with lower risks of incident polypharmacy and incident excessive polypharmacy (HR =0.79 and HR =0.86, p <0.001, respectively). Conclusion: The prevalence and incidence of polypharmacy are high among older adults in Sweden. Interventions aimed at reducing the prevalence of polypharmacy should also target potential incident polypharmacy users as they are the ones who fuel future polypharmacy. Keywords: drugs, older adults, polypharmacy, prescribing, medication, elderly
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wettermark, B., Hammar, N., MichaelFored, C., Leimanis, A., Otterblad Olausson, P., Bergman, U., Persson, I., Sundström, A., Westerholm, B., & Rosén, M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1294 · Cited by 1,887
Mangoni, A. A., & Jackson, S. H. D. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02007.x · Cited by 1,874
Registers of the Swedish total population and their use in medical research
Ludvigsson, J. F., Almqvist, C., Bonamy, A.-K. E., Ljung, R., Michaëlsson, K., Neovius, M., Stephansson, O., & Ye, W. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0117-y · Cited by 1,674
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584
Polypharmacy in elderly patients
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.12.002 · Cited by 1,265
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & Giovannucci, E. L. (2015) · JAMA · doi:10.1001/jama.2015.13766 · Cited by 1,219
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176
Evidence for overuse of medical services around the world
Brownlee, S., Chalkidou, K., Doust, J., Elshaug, A. G., Glasziou, P., Heath, I., Nagpal, S., Saini, V., Srivastava, D., Chalmers, K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32585-5 · Cited by 1,149
A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology
Fortin, M., Stewart, M., Poitras, M.-E., Almirall, J., & Maddocks, H. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1337 · Cited by 1,135
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
Guthrie, B., Makubate, B., Hernandez-Santiago, V., & Dreischulte, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0322-7 · Cited by 838
Managing patients with multimorbidity in primary care
Wallace, E., Salisbury, C., Guthrie, B., Lewis, C., Fahey, T., & Smith, S. M. (2015) · BMJ · doi:10.1136/bmj.h176 · Cited by 742
Adverse drug reactions in special populations – the elderly
Davies, E. A., & O'Mahony, M. S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12596 · Cited by 604
Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010
Charlesworth, C. J., Smit, E., Lee, D. S. H., Alramadhan, F., & Odden, M. C. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv013 · Cited by 570 · cited 1×
“In the United States, data from the National Health and Nutrition Examination Survey indicate that 39% of community-dwelling older adults were exposed to ≥5 prescription drugs in 2012.(3,22) The prevalence of polypharmacy is typically higher in the nursing home setting.”
BackgroundThe challenge of managing drug interactions in elderly people
Mallet, L., Spinewine, A., & Huang, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61092-7 · Cited by 537
Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden
Marengoni, A., Winblad, B., Karp, A., & Fratiglioni, L. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.121137 · Cited by 429
Calderón-Larrañaga, A., Vetrano, D. L., Onder, G., Gimeno-Feliu, L. A., Coscollar-Santaliestra, C., Carfí, A., Pisciotta, M. S., Angleman, S., Melis, R. J. F., Santoni, G., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw233 · Cited by 425
Reconsidering Medication Appropriateness for Patients Late in Life
Holmes, H. M., Hayley, D. C., Alexander, G. C., & Sachs, G. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.6.605 · Cited by 421
Jokanovic, N., Tan, E. C. K., Dooley, M. J., Kirkpatrick, C. M., & Bell, J. S. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.03.003 · Cited by 415
Johnell, K., & Klarin, I. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00009 · Cited by 386
Self-citationConfounding Control in Healthcare Database Research: Challenges and Potential Approaches
Brookhart, M. A., Stürmer, T., Glynn, R. J., Rassen, J., & Schneeweiss, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181dbebe3 · Cited by 377
Validation of pharmacy records in drug exposure assessment
Lau, H. S., de Boer, A., Beuning, K. S., & Porsius, A. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00040-1 · Cited by 370
The development of polypharmacy. A longitudinal study
Veehof, L., Stewart, R., Haaijer-Ruskamp, F., & Jong, B. M.-D. (2000) · Family Practice · doi:10.1093/fampra/17.3.261 · Cited by 347
Cooper, J. A., Cadogan, C. A., Patterson, S. M., Kerse, N., Bradley, M. C., Ryan, C., & Hughes, C. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009235 · Cited by 344
Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study
Onder, G., Liperoti, R., Fialova, D., Topinkova, E., Tosato, M., Danese, P., Gallo, P. F., Carpenter, I., Finne-Soveri, H., Gindin, J., et al. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr233 · Cited by 314
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
Lipska, K. J., Krumholz, H., Soones, T., & Lee, S. J. (2016) · JAMA · doi:10.1001/jama.2016.0299 · Cited by 309
Too much medicine in older people? Deprescribing through shared decision making
Jansen, J., Naganathan, V., Carter, S. M., McLachlan, A. J., Nickel, B., Irwig, L., Bonner, C., Doust, J., Colvin, J., Heaney, A., et al. (2016) · BMJ · doi:10.1136/bmj.i2893 · Cited by 303
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
Cadogan, C. A., Ryan, C., & Hughes, C. M. (2016) · Drug Safety · doi:10.1007/s40264-015-0378-5 · Cited by 298
The clinical implications of ageing for rational drug therapy
Shi, S., Mörike, K., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0422-1 · Cited by 244
Johansson, T., Abuzahra, M. E., Keller, S., Mann, E., Faller, B., Sommerauer, C., Höck, J., Löffler, C., Köchling, A., Schuler, J., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12959 · Cited by 234
Medication prescribing in frail older people
Hubbard, R. E., O’Mahony, M. S., & Woodhouse, K. W. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1387-2 · Cited by 229
O'Dwyer, M., Peklar, J., McCallion, P., McCarron, M., & Henman, M. C. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010505 · Cited by 215
The Epidemiology of Serious Adverse Drug Reactions Among the Elderly
Atkin, P. A., Veitch, P. C., Veitch, E. M., & Ogle, S. J. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00005 · Cited by 203
Methods for estimating the occurrence of polypharmacy by means of a prescription database
Bjerrum, L., Rosholm, J. U., Hallas, J., & Kragstrup, J. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050329 · Cited by 196
Defining polypharmacy in the elderly: a systematic review protocol
Mortazavi, S. S., Shati, M., Keshtkar, A., Malakouti, S. K., Bazargan, M., & Assari, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010989 · Cited by 169
Pharmacokinetics and Pharmacodynamic Changes Associated with Aging and Implications for Drug Therapy
Sera, L. C., & McPherson, M. L. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.01.007 · Cited by 168
Body Composition Remodeling and Mortality: The Health Aging and Body Composition Study
Santanasto, A. J., Goodpaster, B. H., Kritchevsky, S. B., Miljkovic, I., Satterfield, S., Schwartz, A. V., Cummings, S. R., Boudreau, R. M., Harris, T. B., & Newman, A. B. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw163 · Cited by 162
Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study
Jyrkkä, J., Vartiainen, L., Hartikainen, S. A., Sulkava, R. O., & Enlund, H. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0079-6 · Cited by 156
Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians
Bénétos, A., Rossignol, P., Cherubini, A., Joly, L., Grodzicki, T. K., Rajkumar, C., Strandberg, T. E., & Petrović, M. (2015) · JAMA · doi:10.1001/jama.2015.7517 · Cited by 147
Morin, L., Vetrano, D. L., Rizzuto, D., Calderón‐Larrañaga, A., Fastbom, J., & Johnell, K. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.02.028 · Cited by 137
Self-citationUse of Medications of Questionable Benefit in Advanced Dementia
Tjia, J., Briesacher, B. A., Peterson, D., Liu, Q., Andrade, S. E., & Mitchell, S. L. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4103 · Cited by 124
Polypharmacy: a necessary evil
Wise, J. (2013) · BMJ · doi:10.1136/bmj.f7033 · Cited by 123
Exploring Variation in Rates of Polypharmacy Across Long Term Care Homes
Bronskill, S. E., Gill, S. S., Paterson, J. M., Bell, C. M., Anderson, G., & Rochon, P. A. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.07.001 · Cited by 115
Wauters, M., Elseviers, M. M., Vaes, B., Degryse, J., Dalleur, O., Stichele, R. V., Christiaens, T., & Azermai, M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13055 · Cited by 115
Vetrano, D. L., Tosato, M., Colloca, G. A., Topinková, E., Fialová, D., Gindin, J., van der Roest, H. G., Landi, F., Liperoti, R., Bernabei, R., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.09.009 · Cited by 84
Quality of drug prescribing in older patients: is there a problem and can we improve it?
Scott, I. A., & Jayathissa, S. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02040.x · Cited by 82
Johnell, K., & Fastbom, J. (2012) · Drugs & Aging · doi:10.1007/s40266-012-0002-7 · Cited by 74
Self-citationHaasum, Y., Fastbom, J., & Johnell, K. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q597 · Cited by 65
Self-citationWallerstedt, S. M., Fastbom, J., Johnell, K., Sjöberg, C., Landahl, S., & Sundström, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067088 · Cited by 61
Self-citationSjöberg, C., Edward, C., Fastbom, J., Johnell, K., Landahl, S., Narbro, K., & Wallerstedt, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026574 · Cited by 60
Self-citationFranchi, C., Marcucci, M., Mannucci, P. M., Tettamanti, M., Pasina, L., Fortino, I., Bortolotti, A., Merlino, L. G., & Nobili, A. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3938 · Cited by 50
Onder, G., Marengoni, A., Russo, P., Esposti, L. D., Fini, M., Monaco, A., Bonassi, S., Palmer, K., Marrocco, W., Pozzi, G., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.08.009 · Cited by 45
Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study
Abolhassani, N., Castioni, J., Marques-Vidal, P. M., Vollenweider, P., & Waeber, G. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2288-1 · Cited by 40
Polypharmacy in multimorbid older adults: protocol for a systematic review
Sirois, C., Laroche, M., Guénette, L., Kröger, E., Cooper, D., & Émond, V. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0492-9 · Cited by 20
Self-citationMultidose drug dispensing and optimising drug use in older people
Bell, J. S., Johnell, K., Wimmer, B. C., & Wiese, M. D. (2013) · Age and Ageing · doi:10.1093/ageing/aft080 · Cited by 19
Self-citationWastesson, J. W., Oksuzyan, A., Hjelmborg, J., & Christensen, K. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14416 · Cited by 17
Self-citation
Cited by
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Self-citationPolypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
An overview of prevalence, determinants and health outcomes of polypharmacy
Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620933741 · Cited by 443
The Healthy Microbiome—What Is the Definition of a Healthy Gut Microbiome?
Shanahan, F., Ghosh, T. S., & O’Toole, P. W. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.057 · Cited by 383
Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis
Delara, M., Murray, L., Jafari, B., Bahji, A., Goodarzi, Z., Kirkham, J., Chowdhury, M., & Seitz, D. P. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03279-x · Cited by 341
Metadata
- Authors
- Morin, L., Johnell, K., Laroche, M.-L., Fastbom, J., & Wastesson, J. W.
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2018-03
- Volume
- Volume 10
- Pages
- 289-298
- ISSN
- 1179-1349 (ISSN-L)
- OpenAlex
- W2790083419
- Cited by
- 376
- References
- 55
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.